Norpterosin B glucoside

Catalog No. :
ACFEUT979
CAS No. :
1226785-88-1
Molecular Formula :
C19H26O7
Molecular Weight :
366.41

IUPAC Name:(R)-2,5,7-trimethyl-6-((((2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)methyl)-2,3-dihydro-1H-inden-1-one

Norpterosin B glucoside structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5mg98%$373.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameNorpterosin B glucoside
IUPAC Name(R)-2,5,7-trimethyl-6-((((2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)methyl)-2,3-dihydro-1H-inden-1-one
MDL No.MFCD32645047
Molecular FormulaC19H26O7
Molecular Weight366.41
SMILESCC1=CC2=C(C(=O)[C@H](C)C2)C(C)=C1CO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O
InChI KeySPOWTCXDLMRZEG-IRENUKIQSA-N
SynonymNorpterosin B glucoside;(2R)-12-O-β-D-glycopyranosylnorpterosin B;1H-Inden-1-one, 6-[(β-D-glucopyranosyloxy)methyl]-2,3-dihydro-2,5,7-trimethyl-, (2R)-;(2R)-6-[(β-D-Glucopyranosyloxy)methyl]-23-dihydro-257-trimethyl-1H-inden-1-one/NorpterosinBglucoside
CAS No.1226785-88-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACFEUT979 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACFEUT979 route product structure diagram
    ACFEUT9791226785-88-1
Inquiry

2. ACFEUT979 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACFEUT979 route product structure diagram
    ACFEUT9791226785-88-1
Inquiry

Comments (0)